About this trial
The goal of this clinical trial is to evaluate whether an electronic patient-reported outcome measure (ePROM)-guided flexible scheduling system can improve outpatient clinic resource utilisation in patients attending dermatology outpatient clinics for routine follow-up. The main questions it aims to answer are:
* Does the intervention reduce the number of actualised outpatient visits over 12 months compared with standard fixed scheduling? * Does the intervention group achieve higher adherence to monthly ePROM monitoring, as measured by the proportion of completed ePROM submissions?
Eligibility criteria
Qualifiers
Dermatology outpatients otherwise due for a follow-up appointment within six months.
Ability to independently navigate and complete ePROMs.
Ability to provide informed consent (including parental consent for minors).
Disqualifiers
Patients who require fixed or scheduled in-person visits, including those needing skin cancer surveillance, bedside procedures (e.g., liquid nitrogen therapy), surgical interventions, or routine blood tests for immunosuppressive therapy.
Trial design
Treatments tested in this trial
- Flexible ePROM-guided Scheduling System
- electronic patient reported outcome measures (ePROMs)